• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Exec VP Operations Gamble Patrick Dennis bought $41,634 worth of shares (17,000 units at $2.45), increasing direct ownership by 74% to 40,057 units (SEC Form 4)

    12/30/24 4:05:11 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care
    Get the next $QIPT alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Gamble Patrick Dennis

    (Last) (First) (Middle)
    C/O QUIPT HOME MEDICAL CORP.
    1019 TOWN DRIVE

    (Street)
    WILDER KY 41076

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Quipt Home Medical Corp. [ QIPT ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Exec VP Operations
    3. Date of Earliest Transaction (Month/Day/Year)
    12/26/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Shares 12/26/2024 P 7,000 A $2.4191 30,057 D
    Common Shares 12/26/2024 P 10,000 A $2.47 40,057 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    /s/ Patrick Dennis Gamble 12/30/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $QIPT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $QIPT

    DatePrice TargetRatingAnalyst
    5/17/2024Mkt Perform → Underperform
    Raymond James
    2/16/2024Outperform → Mkt Perform
    Raymond James
    6/14/2023$11.00Buy
    Canaccord Genuity
    10/20/2021$7.50Buy
    The Benchmark Company
    10/20/2021$7.50Buy
    Benchmark
    More analyst ratings

    $QIPT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Exec VP Operations Gamble Patrick Dennis bought $41,634 worth of shares (17,000 units at $2.45), increasing direct ownership by 74% to 40,057 units (SEC Form 4)

      4 - Quipt Home Medical Corp. (0001540013) (Issuer)

      12/30/24 4:05:11 PM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care

    $QIPT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Wessel Brian Joseph was granted 183,135 shares, increasing direct ownership by 1,297% to 197,260 units (SEC Form 4)

      4 - Quipt Home Medical Corp. (0001540013) (Issuer)

      3/25/25 7:37:03 AM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care
    • Chief Accounting Officer Roehrig Thomas was granted 110,000 shares, increasing direct ownership by 175% to 173,000 units (SEC Form 4)

      4 - Quipt Home Medical Corp. (0001540013) (Issuer)

      3/25/25 7:36:22 AM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care
    • Chief Compliance Officer Miles Mark Alan was granted 110,000 shares (SEC Form 4)

      4 - Quipt Home Medical Corp. (0001540013) (Issuer)

      3/25/25 7:35:41 AM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care

    $QIPT
    SEC Filings

    See more
    • Quipt Home Medical Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Quipt Home Medical Corp. (0001540013) (Filer)

      5/12/25 5:08:56 PM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form 10-Q filed by Quipt Home Medical Corp.

      10-Q - Quipt Home Medical Corp. (0001540013) (Filer)

      5/12/25 5:04:41 PM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care
    • Amendment: SEC Form SCHEDULE 13D/A filed by Quipt Home Medical Corp.

      SCHEDULE 13D/A - Quipt Home Medical Corp. (0001540013) (Subject)

      4/2/25 8:16:50 AM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care

    $QIPT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Quipt Home Medical Reports Fiscal Second Quarter 2025 Results

      CINCINNATI, May 12, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fiscal second quarter 2025 financial results and operational highlights. These results pertain to the three and six months ended March 31, 2025, and are reported in United States dollars. Conference Call Quipt will host its Earnings Conference Call on Tuesday, May 13, 2025 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing 1 (833) 752-3722 or 1 (647) 846-8549. A live webcast of the call will be accessible via the investor section of the

      5/12/25 5:00:00 PM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care
    • Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2025 Financial Results on May 12, 2025

      CINCINNATI, April 30, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal Second quarter 2025 financial results on Monday, May 12, 2025, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, May 13, 2025, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free:1 (833) 752 3722International:1 (647) 846 8549   A live webcast of the call will be accessible via the investor section of the Company's w

      4/30/25 7:30:00 AM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care
    • Quipt Home Medical Unveils Strategic Priorities for 2025 to Enhance Shareholder Value and Announces Voting Results from its Annual General Meeting

      CINCINNATI, March 24, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce its strategic priorities for calendar 2025 and the voting results from its annual general meeting of shareholders held on March 17, 2025 (the "Meeting") in Sarasota, Florida. The total number of shares represented in person or by proxy at the Meeting was 31,400,043, representing 72.87% of the total issued and outstanding shares in the capital of the Company. As it relates to its strategic priorities for 2025, the Company remains committed to returning to hist

      3/24/25 7:30:00 AM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care

    $QIPT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by Quipt Home Medical Corp.

      SC 13D - Quipt Home Medical Corp. (0001540013) (Subject)

      12/11/24 4:07:36 PM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Quipt Home Medical Corp.

      SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)

      12/11/24 4:06:42 PM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13G filed by Quipt Home Medical Corp.

      SC 13G - Quipt Home Medical Corp. (0001540013) (Subject)

      12/11/24 4:06:09 PM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care

    $QIPT
    Leadership Updates

    Live Leadership Updates

    See more
    • Quipt Home Medical Unveils Strategic Priorities for 2025 to Enhance Shareholder Value and Announces Voting Results from its Annual General Meeting

      CINCINNATI, March 24, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce its strategic priorities for calendar 2025 and the voting results from its annual general meeting of shareholders held on March 17, 2025 (the "Meeting") in Sarasota, Florida. The total number of shares represented in person or by proxy at the Meeting was 31,400,043, representing 72.87% of the total issued and outstanding shares in the capital of the Company. As it relates to its strategic priorities for 2025, the Company remains committed to returning to hist

      3/24/25 7:30:00 AM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care
    • Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders

      CINCINNATI, March 28, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders held on March 27, 2024 (the "Meeting") in Wilder, Kentucky. The total number of shares represented in person or by proxy at the Meeting was 25,432,699, representing 60.4% of the total issued and outstanding shares in the capital of the Company. Election of Directors The four candidates nominated for election to the Company's Board of Directors (the "Board") and listed in the Company's manageme

      3/28/24 7:30:00 AM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care
    • Quipt Home Medical Announces New Independent Board Member

      CINCINNATI, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, announced today that Mr. Brian J. Wessel has joined the Board of Directors of the Company as an Independent Director and Chair of the Audit Committee. Mr. Wessel is a senior business executive with over 34 years of global client service, operational and financial expertise. As a former senior partner at Ernst & Young ("EY"), Mr. Wessel provided audit and advisory services to public, private, and private-equity-owned companies across multiple industry sectors. Additio

      2/3/22 7:30:00 AM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care

    $QIPT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Quipt Home Medical downgraded by Raymond James

      Raymond James downgraded Quipt Home Medical from Mkt Perform to Underperform

      5/17/24 7:45:25 AM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care
    • Quipt Home Medical downgraded by Raymond James

      Raymond James downgraded Quipt Home Medical from Outperform to Mkt Perform

      2/16/24 8:29:00 AM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care
    • Canaccord Genuity resumed coverage on Quipt Home Medical with a new price target

      Canaccord Genuity resumed coverage of Quipt Home Medical with a rating of Buy and set a new price target of $11.00

      6/14/23 8:58:25 AM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care

    $QIPT
    Financials

    Live finance-specific insights

    See more
    • Quipt Home Medical Reports Fiscal Second Quarter 2025 Results

      CINCINNATI, May 12, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fiscal second quarter 2025 financial results and operational highlights. These results pertain to the three and six months ended March 31, 2025, and are reported in United States dollars. Conference Call Quipt will host its Earnings Conference Call on Tuesday, May 13, 2025 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing 1 (833) 752-3722 or 1 (647) 846-8549. A live webcast of the call will be accessible via the investor section of the

      5/12/25 5:00:00 PM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care
    • Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2025 Financial Results on May 12, 2025

      CINCINNATI, April 30, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal Second quarter 2025 financial results on Monday, May 12, 2025, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, May 13, 2025, at 10:00 a.m. (ET). The call-in numbers for participants are: Canada/US Toll Free:1 (833) 752 3722International:1 (647) 846 8549   A live webcast of the call will be accessible via the investor section of the Company's w

      4/30/25 7:30:00 AM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care
    • Quipt Home Medical Reports First Quarter Fiscal Year 2025 Financial Results

      CINCINNATI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its first quarter fiscal year 2025 financial results and operational highlights. These results pertain to the three months ended December 31, 2024 and are reported in U.S. Dollars. Conference Call Quipt will host its Earnings Conference Call on Tuesday, February 11, 2025 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing 1 (844) 763-8274 or 1 (647) 484-8814. A live webcast of the call will be accessible via the Company's website at https:/

      2/10/25 5:00:00 PM ET
      $QIPT
      Misc Health and Biotechnology Services
      Health Care